Skip to main content

Table 1 Clinical and sociodemographic characteristics of patients with and without on target LDL-C levels

From: Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study)

Variables

Total Patients

(n = 4504)

Patients with LDL-C on target

(n = 922, 20.5%)

Patients with LDL-C not on target

(n = 3582, 79.5%)

p

Gender (Female n,%)

2639 (58.6)

475 (51.5)

2164 (60.4)

< 0.001

Age (year)

58.6 ± 10.4

58.4 (±10.5)

58.6 (±10.4)

0.68

BMI (kg/m2)

32.1 ± 6.5

31.8 (±6.6)

32.1 (±6.4)

0.12

SBP (mmHg)

132.5 ± 18.3

131.4 (±18.1)

132.8 (±18.4)

0.03

DBP (mmHg)

80.5 ± 10.7

80.0 (±10.7)

80.6 (±10.7)

0.17

Diabetes duration (year)

10.9 ± 7.5

10.8 (±7.4)

11.0 (±7.5)

0.46

Active smoking (n,%)

561 (12.5)

119 (13.0)

442 (12.4)

0.61

HbA1c (%)

7.73 ± 1.74

7.60 (±1.64)

7.75 (±1.77)

0.015

HbA1c levels < 7%

1790 (40.2)

390 (42.7)

1400 (39.5)

0.085

Exercise (n,%)

883 (19.6)

226 (24.7)

657 (18.6)

< 0.001

Higher education (n,%)

1722 (38.2)

369 (40.4)

1353 (38.4)

0.26

Private center follow-up (n,%)

483 (10.2)

123 (13.3)

342 (9.5)

0.001

Microvascular complications (n,%)

2142 (47.6)

222 (24.1)

1920 (53.6)

< 0.001

 Retinopathy (n,%)

874 (21.3)

107 (12.5)

767 (23.7)

< 0.001

 Nephropathy (n,%)

817 (19.6)

84 (9.7)

733 (22.2)

< 0.001

 Neuropathy (n,%)

1545 (34.7)

163 (17.9)

1382 (39.0)

< 0.001

Macrovascular complications (n,%)

1103 (24.5)

165 (17.9)

938 (26.2)

< 0.001

 Coronary artery disease (n,%)

962 (21.4)

151 (17.7)

811 (24.5)

< 0.001

 Peripheral artery disease (n,%)

175 (4.2)

28 (3.2)

147 (4.4)

0.11

 Cerebrovascular disease (n,%)

132 (3.0)

19 (2.1)

113 (3.3)

0.07

Obesity (n,%)

2593 (58.3)

472 (51.7)

2027 (56.8)

0.005

Hypertension (n,%)

3074 (68.6)

621 (67.8)

2453 (68.8)

0.58

 Blood pressure on target (n,%)

3128 (69.9)

668 (73.1)

2460 (69.1)

0.020

LDL-Cholesterol (mg/dl)

113.9 (±36.2)

73.8 (±17.1)

124.2 (±32.4)

< 0.001

HDL-Cholesterol (mg/dl)

46.5 (±12.9)

45.5 (±14.7)

46.9 (±12.4)

0.005

 HDL- Cholesterol on target (n,%)

1978 (43.9)

376 (41.8)

1602 (46.8)

0.007

Triglycerides (mg/dl)

182.1 (±128.7)

164.0 (±113.7)

181.4 (±115.8)

< 0.001

 Triglycerides on target (n,%)

2272 (50.4)

529 (57.8)

1743 (48.8)

< 0.001

Statin treatment (n,%)

1807 (40.1)

448 (48.6)

1359 (37.9)

< 0.001

 High intensity statin (n,%)

181 (4.0)

41 (22.7)

140 (77.3)

0.48

  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HbA1c glycosylated hemoglobin, LDL low-density lipoprotein, HDL high-density lipoprotein, Data are expressed as (mean ± SD) number (%) where appropriate
  2. p-values are derived from Student’s t-test and Chi-square tests for continuous and categorical variables, respectively